Literature DB >> 9738977

Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemia.

J Takizawa1, R Suzuki, H Kuroda, A Utsunomiya, Y Kagami, T Joh, Y Aizawa, R Ueda, M Seto.   

Abstract

The TCL1 gene was recently cloned as a candidate target within the 14q32.1 breakpoint cluster region observed in T-cell malignancies. We examined the TCL1 gene expression in 21 patients with adult T-cell leukemia (ATL) and 5 cell lines, because ATL is reported to have frequent chromosome 14 band q32 aberrations. However, 20 of the ATL patients and all 5 cell lines lacked any TCL1 expression on northern blot analysis, and TCL1 transcripts were only very faintly detected in the remaining one patient. Expansion of our analysis to include other types of hematopoietic malignancies revealed strong expression of the TCL1 gene in almost all tumor cells of B-cell lineage except myelomas. However, no TCL1 signals were encountered in cells of T-cell or myeloid lineages. In normal human tissues TCL1 was found to be expressed in the spleen, lymph nodes and B-lymphocytes of peripheral blood. These results indicate that TCL1 is not a major target gene for ATL, but that it may play a role in B-cell differentiation and proliferation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9738977      PMCID: PMC5921886          DOI: 10.1111/j.1349-7006.1998.tb03275.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  16 in total

Review 1.  Translocations, master genes, and differences between the origins of acute and chronic leukemias.

Authors:  T H Rabbitts
Journal:  Cell       Date:  1991-11-15       Impact factor: 41.582

2.  Characterization and localization of the TCL-1 oncogene product.

Authors:  T B Fu; L Virgilio; M G Narducci; A Facchiano; G Russo; C M Croce
Journal:  Cancer Res       Date:  1994-12-15       Impact factor: 12.701

3.  Molecular analysis of a t(14;14) translocation in leukemic T-cells of an ataxia telangiectasia patient.

Authors:  G Russo; M Isobe; R Gatti; J Finan; O Batuman; K Huebner; P C Nowell; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

4.  Identification of the TCL1 gene involved in T-cell malignancies.

Authors:  L Virgilio; M G Narducci; M Isobe; L G Billips; M D Cooper; C M Croce; G Russo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

5.  TCL1 is overexpressed in patients affected by adult T-cell leukemias.

Authors:  M G Narducci; A Stoppacciaro; K Imada; T Uchiyama; L Virgilio; C Lazzeri; C M Croce; G Russo
Journal:  Cancer Res       Date:  1997-12-15       Impact factor: 12.701

6.  Chromosome abnormalities in adult T-cell leukemia/lymphoma: a karyotype review committee report.

Authors:  N Kamada; M Sakurai; K Miyamoto; I Sanada; N Sadamori; S Fukuhara; S Abe; Y Shiraishi; T Abe; Y Kaneko
Journal:  Cancer Res       Date:  1992-03-15       Impact factor: 12.701

7.  MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations.

Authors:  M H Stern; J Soulier; M Rosenzwajg; K Nakahara; N Canki-Klain; A Aurias; F Sigaux; I R Kirsch
Journal:  Oncogene       Date:  1993-09       Impact factor: 9.867

Review 8.  Leukemia and lymphoma in ataxia telangiectasia.

Authors:  A M Taylor; J A Metcalfe; J Thick; Y F Mak
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

9.  TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia.

Authors:  M G Narducci; L Virgilio; M Isobe; A Stoppacciaro; R Elli; M Fiorilli; M Carbonari; A Antonelli; L Chessa; C M Croce; G Russo
Journal:  Blood       Date:  1995-09-15       Impact factor: 22.113

10.  Establishment and characterization of a human T-cell lymphoblastic lymphoma cell line (HT-1) carrying an inversion of chromosome 14.

Authors:  M Abe; K Tasaki; Y Nozawa; K Tominaga; S Fukuhara; T Ohsato; H Wakasa
Journal:  Cancer       Date:  1992-03-01       Impact factor: 6.860

View more
  11 in total

1.  TCL1 oncogene expression in AIDS-related lymphomas and lymphoid tissues.

Authors:  M Teitell; M A Damore; G G Sulur; D E Turner; M H Stern; J W Said; C T Denny; R Wall
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.

Authors:  Luciano Mazzoccoli; Marcela Cristina Robaina; Alexandre Gustavo Apa; Martin Bonamino; Luciana Wernersbach Pinto; Eduardo Queiroga; Carlos E Bacchi; Claudete Esteves Klumb
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-09       Impact factor: 4.553

3.  Synergy of Myc, cell cycle regulators and the Akt pathway in the development of aggressive B-cell lymphoma in a mouse model.

Authors:  K Arita; S Tsuzuki; K Ohshima; T Sugiyama; M Seto
Journal:  Leukemia       Date:  2014-07-18       Impact factor: 11.528

4.  Genomic analysis of human and mouse TCL1 loci reveals a complex of tightly clustered genes.

Authors:  C Hallas; Y Pekarsky; T Itoyama; J Varnum; R Bichi; J L Rothstein; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

Review 5.  The long journey of TCL1 transgenic mice: lessons learned in the last 15 years.

Authors:  Yuri Pekarsky; Alessandra Drusco; Prasanthi Kumchala; Carlo M Croce; Nicola Zanesi
Journal:  Gene Expr       Date:  2015

6.  Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.

Authors:  Roberta Bichi; Susan A Shinton; Eric S Martin; Anatoliy Koval; George A Calin; Rossano Cesari; Giandomenico Russo; Richard R Hardy; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-14       Impact factor: 11.205

7.  Abnormalities at 14q32.1 in T cell malignancies involve two oncogenes.

Authors:  Y Pekarsky; C Hallas; M Isobe; G Russo; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

8.  High TCL1 expression and intact T-cell receptor signaling define a hyperproliferative subset of T-cell prolymphocytic leukemia.

Authors:  Marco Herling; Kaushali A Patel; Michael A Teitell; Marina Konopleva; Farhad Ravandi; Ryuji Kobayashi; Dan Jones
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

9.  Whole-transcriptome analysis of flow-sorted cervical cancer samples reveals that B cell expressed TCL1A is correlated with improved survival.

Authors:  Simone Punt; Willem E Corver; Sander A J van der Zeeuw; Szymon M Kielbasa; Elisabeth M Osse; Henk P J Buermans; Cornelis D de Kroon; Ekaterina S Jordanova; Arko Gorter
Journal:  Oncotarget       Date:  2015-11-17

10.  TCL1 participates in early embryonic development and is overexpressed in human seminomas.

Authors:  Maria Grazia Narducci; Maria Teresa Fiorenza; Sang-Moo Kang; Arturo Bevilacqua; Monica Di Giacomo; Daniele Remotti; Maria Cristina Picchio; Vincenzo Fidanza; Max D Cooper; Carlo Maria Croce; Franco Mangia; Giandomenico Russo
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.